Interaction between murine spf-ash mutation and genetic background yields different metabolic phenotypes

Juan C. Marini, Ayelet Erez, Leticia Castillo, Brendan Lee

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The spf-ash mutation in mice results in reduced hepatic and intestinal ornithine transcarbamylase. However, a reduction in enzyme activity only translates in reduced ureagenesis and hyperammonemia when an unbalanced nitrogen load is imposed. Six-week-old wild-type control and spf-ash mutant male mice from different genetic backgrounds (B6 and ICR) were infused intravenously with [13C18O]urea, L-[15N2]arginine, L-[5,5 D2]ornithine, L-[6-13C, 4,4,5,5, D 4]citrulline, and L-[ring-D5]phenylalanine to investigate the interaction between genetic background and spf-ash mutation on ureagenesis, arginine metabolism, and nitric oxide production. ICRspf-ash mice maintained ureagenesis (5.5 ± 0.3 mmol·kg-1 ·h-1) and developed mild hyperammonemia (145 ± 19 μmol/l) when an unbalanced nitrogen load was imposed; however, B6 spf-ash mice became hyperammonemic (671 ± 15 μmol/l) due to compromised ureagenesis (3.4 ± 0.1 mmol·kg -1·h-1). Ornithine supplementation restored ureagenesis and mitigated hyperammonemia. A reduction in citrulline entry rate was observed due to the mutation in both genetic backgrounds (wild-type: 128, spf-ash: 60; SE 4.0 μmol·kg-1·h-1). Arginine entry rate was only reduced in B6spf-ash mice (B6 spf-ash: 332, ICRspf-ash: 453; SE 20.6 μmol·kg-1 ·h-1). Genetic background and mutation had an effect on nitric oxide production (B6: 3.4, B6 spf-ash: 2.8, ICR: 9.0, ICRspf-ash: 4.6, SE 0.7 μmol·kg-1·h-1). Protein breakdown was the main source of arginine during the postabsorptive state and was higher in ICRspf-ash than in B6spf-ash mice (phenylalanine entry rate 479 and 327, respectively; SE 18 μmol·kg-1 ·h-1). Our results highlight the importance of the interaction between mutation and genetic background on ureagenesis, arginine metabolism, and nitric oxide production. These observations help explain the wide phenotypic variation of ornithine transcarbamylase deficiency in the human population.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume293
Issue number6
DOIs
StatePublished - Dec 1 2007
Externally publishedYes

Fingerprint

Ashes
Arginine
Hyperammonemia
Phenotype
Mutation
Citrulline
Nitric Oxide
Ornithine
Phenylalanine
Nitrogen
Ornithine Carbamoyltransferase Deficiency Disease
Ornithine Carbamoyltransferase
Metabolism
Urea
Genetic Background

Keywords

  • Arginine
  • Nitric oxide
  • Urea cycle

ASJC Scopus subject areas

  • Physiology
  • Endocrinology
  • Biochemistry

Cite this

Interaction between murine spf-ash mutation and genetic background yields different metabolic phenotypes. / Marini, Juan C.; Erez, Ayelet; Castillo, Leticia; Lee, Brendan.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 293, No. 6, 01.12.2007.

Research output: Contribution to journalArticle

@article{1f6329cd8e0a4ad2a29559505322205d,
title = "Interaction between murine spf-ash mutation and genetic background yields different metabolic phenotypes",
abstract = "The spf-ash mutation in mice results in reduced hepatic and intestinal ornithine transcarbamylase. However, a reduction in enzyme activity only translates in reduced ureagenesis and hyperammonemia when an unbalanced nitrogen load is imposed. Six-week-old wild-type control and spf-ash mutant male mice from different genetic backgrounds (B6 and ICR) were infused intravenously with [13C18O]urea, L-[15N2]arginine, L-[5,5 D2]ornithine, L-[6-13C, 4,4,5,5, D 4]citrulline, and L-[ring-D5]phenylalanine to investigate the interaction between genetic background and spf-ash mutation on ureagenesis, arginine metabolism, and nitric oxide production. ICRspf-ash mice maintained ureagenesis (5.5 ± 0.3 mmol·kg-1 ·h-1) and developed mild hyperammonemia (145 ± 19 μmol/l) when an unbalanced nitrogen load was imposed; however, B6 spf-ash mice became hyperammonemic (671 ± 15 μmol/l) due to compromised ureagenesis (3.4 ± 0.1 mmol·kg -1·h-1). Ornithine supplementation restored ureagenesis and mitigated hyperammonemia. A reduction in citrulline entry rate was observed due to the mutation in both genetic backgrounds (wild-type: 128, spf-ash: 60; SE 4.0 μmol·kg-1·h-1). Arginine entry rate was only reduced in B6spf-ash mice (B6 spf-ash: 332, ICRspf-ash: 453; SE 20.6 μmol·kg-1 ·h-1). Genetic background and mutation had an effect on nitric oxide production (B6: 3.4, B6 spf-ash: 2.8, ICR: 9.0, ICRspf-ash: 4.6, SE 0.7 μmol·kg-1·h-1). Protein breakdown was the main source of arginine during the postabsorptive state and was higher in ICRspf-ash than in B6spf-ash mice (phenylalanine entry rate 479 and 327, respectively; SE 18 μmol·kg-1 ·h-1). Our results highlight the importance of the interaction between mutation and genetic background on ureagenesis, arginine metabolism, and nitric oxide production. These observations help explain the wide phenotypic variation of ornithine transcarbamylase deficiency in the human population.",
keywords = "Arginine, Nitric oxide, Urea cycle",
author = "Marini, {Juan C.} and Ayelet Erez and Leticia Castillo and Brendan Lee",
year = "2007",
month = "12",
day = "1",
doi = "10.1152/ajpendo.00525.2007",
language = "English (US)",
volume = "293",
journal = "American Journal of Physiology - Endocrinology and Metabolism",
issn = "0193-1849",
publisher = "American Physiological Society",
number = "6",

}

TY - JOUR

T1 - Interaction between murine spf-ash mutation and genetic background yields different metabolic phenotypes

AU - Marini, Juan C.

AU - Erez, Ayelet

AU - Castillo, Leticia

AU - Lee, Brendan

PY - 2007/12/1

Y1 - 2007/12/1

N2 - The spf-ash mutation in mice results in reduced hepatic and intestinal ornithine transcarbamylase. However, a reduction in enzyme activity only translates in reduced ureagenesis and hyperammonemia when an unbalanced nitrogen load is imposed. Six-week-old wild-type control and spf-ash mutant male mice from different genetic backgrounds (B6 and ICR) were infused intravenously with [13C18O]urea, L-[15N2]arginine, L-[5,5 D2]ornithine, L-[6-13C, 4,4,5,5, D 4]citrulline, and L-[ring-D5]phenylalanine to investigate the interaction between genetic background and spf-ash mutation on ureagenesis, arginine metabolism, and nitric oxide production. ICRspf-ash mice maintained ureagenesis (5.5 ± 0.3 mmol·kg-1 ·h-1) and developed mild hyperammonemia (145 ± 19 μmol/l) when an unbalanced nitrogen load was imposed; however, B6 spf-ash mice became hyperammonemic (671 ± 15 μmol/l) due to compromised ureagenesis (3.4 ± 0.1 mmol·kg -1·h-1). Ornithine supplementation restored ureagenesis and mitigated hyperammonemia. A reduction in citrulline entry rate was observed due to the mutation in both genetic backgrounds (wild-type: 128, spf-ash: 60; SE 4.0 μmol·kg-1·h-1). Arginine entry rate was only reduced in B6spf-ash mice (B6 spf-ash: 332, ICRspf-ash: 453; SE 20.6 μmol·kg-1 ·h-1). Genetic background and mutation had an effect on nitric oxide production (B6: 3.4, B6 spf-ash: 2.8, ICR: 9.0, ICRspf-ash: 4.6, SE 0.7 μmol·kg-1·h-1). Protein breakdown was the main source of arginine during the postabsorptive state and was higher in ICRspf-ash than in B6spf-ash mice (phenylalanine entry rate 479 and 327, respectively; SE 18 μmol·kg-1 ·h-1). Our results highlight the importance of the interaction between mutation and genetic background on ureagenesis, arginine metabolism, and nitric oxide production. These observations help explain the wide phenotypic variation of ornithine transcarbamylase deficiency in the human population.

AB - The spf-ash mutation in mice results in reduced hepatic and intestinal ornithine transcarbamylase. However, a reduction in enzyme activity only translates in reduced ureagenesis and hyperammonemia when an unbalanced nitrogen load is imposed. Six-week-old wild-type control and spf-ash mutant male mice from different genetic backgrounds (B6 and ICR) were infused intravenously with [13C18O]urea, L-[15N2]arginine, L-[5,5 D2]ornithine, L-[6-13C, 4,4,5,5, D 4]citrulline, and L-[ring-D5]phenylalanine to investigate the interaction between genetic background and spf-ash mutation on ureagenesis, arginine metabolism, and nitric oxide production. ICRspf-ash mice maintained ureagenesis (5.5 ± 0.3 mmol·kg-1 ·h-1) and developed mild hyperammonemia (145 ± 19 μmol/l) when an unbalanced nitrogen load was imposed; however, B6 spf-ash mice became hyperammonemic (671 ± 15 μmol/l) due to compromised ureagenesis (3.4 ± 0.1 mmol·kg -1·h-1). Ornithine supplementation restored ureagenesis and mitigated hyperammonemia. A reduction in citrulline entry rate was observed due to the mutation in both genetic backgrounds (wild-type: 128, spf-ash: 60; SE 4.0 μmol·kg-1·h-1). Arginine entry rate was only reduced in B6spf-ash mice (B6 spf-ash: 332, ICRspf-ash: 453; SE 20.6 μmol·kg-1 ·h-1). Genetic background and mutation had an effect on nitric oxide production (B6: 3.4, B6 spf-ash: 2.8, ICR: 9.0, ICRspf-ash: 4.6, SE 0.7 μmol·kg-1·h-1). Protein breakdown was the main source of arginine during the postabsorptive state and was higher in ICRspf-ash than in B6spf-ash mice (phenylalanine entry rate 479 and 327, respectively; SE 18 μmol·kg-1 ·h-1). Our results highlight the importance of the interaction between mutation and genetic background on ureagenesis, arginine metabolism, and nitric oxide production. These observations help explain the wide phenotypic variation of ornithine transcarbamylase deficiency in the human population.

KW - Arginine

KW - Nitric oxide

KW - Urea cycle

UR - http://www.scopus.com/inward/record.url?scp=37149024528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37149024528&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.00525.2007

DO - 10.1152/ajpendo.00525.2007

M3 - Article

VL - 293

JO - American Journal of Physiology - Endocrinology and Metabolism

JF - American Journal of Physiology - Endocrinology and Metabolism

SN - 0193-1849

IS - 6

ER -